| 000 | 01687cam a22004574a 4500 | ||
|---|---|---|---|
| 005 | 20150712005512.0 | ||
| 008 | 090326s2009 nyua b 001 0 eng | ||
| 010 | _a 2009012458 | ||
| 016 | 7 |
_a101500278 _2DNLM |
|
| 020 | _a9781420073171 | ||
| 020 | _a1420073176 | ||
| 035 | _a(OCoLC)ocn317664257 | ||
| 040 |
_aDNLM/DLC _cDLC _dBTCTA _dBAKER _dYDXCP _dNLM _dC\P _dBWX _dDLC |
||
| 042 | _apcc | ||
| 060 | _bG P | ||
| 082 | 0 | 0 |
_a615.1 _222 |
| 084 |
_a615.1 _bG P |
||
| 100 | 1 | _aGibson , Mark. | |
| 245 | 1 | 0 |
_aPharmaceutical preformulation and formulation _h[[Book] :] _ba practical guide from candidate drug selection to commercial dosage form / _cMark Gibson. |
| 250 | _a2nd ed. | ||
| 260 |
_aNew York : _bInforma Healthcare , _c2009. |
||
| 300 |
_ax, 541 p. : _bill. ; _c27 cm. |
||
| 490 | 1 |
_aDrugs and the pharmaceutical sciences ; _vv. 199 |
|
| 504 | _aIncludes bibliographical references and index. | ||
| 521 | _aAll age. | ||
| 650 | 0 |
_aDrugs _xDosage forms. |
|
| 650 | 1 | 2 | _aDrug Compounding. |
| 650 | 2 | 2 |
_aBiopharmaceutics _xmethods. |
| 650 | 2 | 2 | _aDosage Forms. |
| 650 | 2 | 2 | _aDrug Discovery. |
| 650 | 2 | 2 | _aDrug Evaluation. |
| 700 | 1 |
_aGibson, Mark, _d1957- |
|
| 830 | 0 |
_aDrugs and the pharmaceutical sciences ; _vv. 199. |
|
| 906 |
_a7 _bcbc _corignew _d1 _eecip _f20 _gy-gencatlg |
||
| 925 | 0 |
_aacquire _b1 shelf copy _xpolicy default |
|
| 901 | _aTO LC: 1st ed. in LC OPAC: 2001016816 | ||
| 955 |
_dxh11 2009-03-30 to shelflisting _exh08 2009-03-31 to DEWEY _axh06 2009-04-01 reviewed _ard13 2009-04-01 _axe10 2009-12-08 1 copy rec'd., to CIP ver. _axh00 2009-12-11 to USPL/STM _fxh14 2009-12-14 Z-CipVer to BCCD |
||
| 001 | 0000072868 | ||
| 003 | 0000 | ||
| 942 | _cBK | ||
| 999 |
_c53453 _d53453 |
||